Tags

Type your tag names separated by a space and hit enter

[On the treatment of arteriosclerotic retinopathy with Cosaldon A+E (author's transl)].

Abstract

Cosaldon A+E was applied in 61 patients, most of whom presented severe vascular degenerative retinochoroidal circulatory disorders and chronic glaucoma. The treatment, mostly consisting of 3--2 x 1 tablet per day, was well tolerated and resulted in marked (43 patients) and moderate (8 patients) improvement of visual function. In ten patients the symptoms remained unchanged. Particularly the improvement found in 4 patients presenting chronic glaucoma "without pressure" are worth mentioning. Besides, the symptomatology of chronic cerebrovascular insufficiency presented by most of the patients was positively influenced. Cosaldon A+E above all renders more promising the treatment of vascular processes in the eye-ground, such as the chorioretinopathy, which, in view of the unfavourable prognosis of the disease, is deemed a remarkable progress. Likewise the product seems to exert a beneficial effect in patients with chronic glaucoma.

Authors

Source

MeSH

Adult
Aged
Arteriosclerosis
Chorioretinitis
Drug Combinations
Female
Humans
Male
Middle Aged
Nicotinic Acids
Theobromine
Vasodilator Agents

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

732204

Citation

Zielinski, H W.. "[On the Treatment of Arteriosclerotic Retinopathy With Cosaldon A+E (author's Transl)]." Klinische Monatsblatter Fur Augenheilkunde, vol. 173, no. 6, 1978, pp. 857-64.
Zielinski HW. [On the treatment of arteriosclerotic retinopathy with Cosaldon A+E (author's transl)]. Klin Monbl Augenheilkd. 1978;173(6):857-64.
Zielinski, H. W. (1978). [On the treatment of arteriosclerotic retinopathy with Cosaldon A+E (author's transl)]. Klinische Monatsblatter Fur Augenheilkunde, 173(6), pp. 857-64.
Zielinski HW. [On the Treatment of Arteriosclerotic Retinopathy With Cosaldon A+E (author's Transl)]. Klin Monbl Augenheilkd. 1978;173(6):857-64. PubMed PMID: 732204.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [On the treatment of arteriosclerotic retinopathy with Cosaldon A+E (author's transl)]. A1 - Zielinski,H W, PY - 1978/12/1/pubmed PY - 1978/12/1/medline PY - 1978/12/1/entrez SP - 857 EP - 64 JF - Klinische Monatsblatter fur Augenheilkunde JO - Klin Monbl Augenheilkd VL - 173 IS - 6 N2 - Cosaldon A+E was applied in 61 patients, most of whom presented severe vascular degenerative retinochoroidal circulatory disorders and chronic glaucoma. The treatment, mostly consisting of 3--2 x 1 tablet per day, was well tolerated and resulted in marked (43 patients) and moderate (8 patients) improvement of visual function. In ten patients the symptoms remained unchanged. Particularly the improvement found in 4 patients presenting chronic glaucoma "without pressure" are worth mentioning. Besides, the symptomatology of chronic cerebrovascular insufficiency presented by most of the patients was positively influenced. Cosaldon A+E above all renders more promising the treatment of vascular processes in the eye-ground, such as the chorioretinopathy, which, in view of the unfavourable prognosis of the disease, is deemed a remarkable progress. Likewise the product seems to exert a beneficial effect in patients with chronic glaucoma. SN - 0023-2165 UR - https://www.unboundmedicine.com/medline/citation/732204/[On_the_treatment_of_arteriosclerotic_retinopathy_with_Cosaldon_A+E__author's_transl_]_ L2 - http://www.diseaseinfosearch.org/result/6288 DB - PRIME DP - Unbound Medicine ER -